HR Execs on the Move

Cytrellis

www.cytrellis.com

 
Cytrellis is a medical technology company dedicated to the development and commercialization of first-in-class aesthetic devices which emphasize safety, efficacy, and improved quality of life for our patients. Cytrellis` first product, the ellacor® System with Micro-Coring™ Technology, is indicated for use by medical professionals for the treatment of moderate to severe wrinkles in the mid to lower face in adults aged 22 years or older with Fitzpatrick skin types I-IV. Ellacor provides aesthetic practitioners with an unprecedented ability to improve age-related changes in skin and to help restore youthful beauty.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Jackson McAdam
 Chief Financial Officer Profile
Karen Cronholm
 President and Chief Executive Officer Profile

Similar Companies

Mark Products

Mark Products is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

medical supply net

medical supply net is a San Dimas, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Movano

Founded in 2018, Movano Inc. is a health-focused technology company creating simple, smart and personalized devices designed to inspire and empower individuals on their health journey live a happier, healthier life. Movano`s technology is being developed to provide vital health information, including glucose and blood pressure data, in a variety of form factors to meet individual style needs and give users actionable feedback in order to improve the quality of their life.

Omni International, LLC

Omni International, LLC is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

TransMedics

TransMedics Inc. is the world`s leader in portable ex-vivo perfusion and assessment of donor organs for transplantation. The company was founded to address the need for more and better organs for transplantation, and is focused on transforming the standard of care – increasing organ utilization, improving patient outcomes, and reducing transplant costs throughout the heath care system. The OCS Lung, OCS Heart and OCS Liver are all CE marked and FDA approved devices.